Skip to content
Research Article Open access CC BY 4.0

Prevalence of Malaria with Anaemia and HIV Status in Women of Reproductive Age in Onitsha, Nigeria

Vivian Chinenye Ezeoru, Ifeoma Bessie Enweani, Ogochukwu Ochiabuto, Anthonia Chinwe Nwachukwu, Ugoy Sonia Ogbonna, Emmanuel Ifeanyi Obeagu

Journal of Pharmaceutical Research International · pp. 10–19 · Published 23 Feb 2021

10.9734/jpri/2021/v33i431166

Abstract

The major health problems affecting pregnant women in sub-Saharan African are anaemia, malaria and HIV. A case-control study aimed at determining the prevalence of malaria, anaemia and HIV status among women of reproductive age between 20-49 years attending General Hospital, Onitsha was conducted. Blood samples of three hundred and sixty-two apparently healthy gravid women attending antenatal and 181 non-gravid apparently healthy women in Onitsha were recruited using random sampling method. A structured questionnaire was used for data collection. Haemoglobin was estimated using automated method, Malaria, diagnosed microscopically using gold standard staining method and HIV screened using qualitative immunochromatographic method, confirmed molecularly. Statistical analysis was done using SPSS version 21. Results revealed that out of the 362 pregnant test groups,125 (34.5%) had malaria parasite (mp) in their blood and were anaemic 53(37.6%)  though fewer in control groups ;23,14 (12.7%; 16.1%)  (p = 0.195; p =0.055). Out of 347 HIV sero-negative pregnant women, 110 (31.7%) tested HIV positive when confirmed by PCR molecular method while only 1(0.6%) sero-negative controls were confirmed positive with molecular method with statistical significance observed in the test and control groups (p = 0.000; p = 0.000). However, as pregnancy affects HIV serology testing, it is necessary to use molecular method to increase its sensitivity and more enlightment  programmes on the importance of balanced diet, compliance to Malaria control and routine gynecological drugs intake in pregnant women.

Malaria control anaemia reproductive age pregnant women HIV.

Cited by 40

Evaluation of Activated Partial Thromboplastin Time and Prothrombin Time in HIV and TB Patients in Owerri Metropolis

I. L. Okoroiwu, E. Obeagu, Queen Braxton N. Anaebo · Journal of Pharmaceutical Research International · 2022

Adherence to Antiretroviral Therapy among HIV/AIDS in Federal Medical Centre, Owerri

C. Vincent, E. I. Obeagu, I. Agu · Journal of Pharmaceutical Research International · 2021

Facilitators and Barriers to Retention in HIV Care among HIV Infected MSM Attending Community Health Center Yaba, Lagos Nigeria

D. Offie, E. Obeagu, Chiedozi Akueshi · Journal of Pharmaceutical Research International · 2021

Antiretroviral Therapy and Red Blood Cell Morphology: A Review in HIV Patients

E. Obeagu · Haematology International Journal · 2024

Placental Malarial Infection:A Review

E. Obeagu, Carine Byukusenge, Gertrude Namulondo

World Journal of Critical Care Medicine

J. Ebogo-Belobo, S. Kenmoe, Chris Andre

Systematic review and meta-analysis of seroprevalence of human immunodeficiency virus serological markers among pregnant women in Africa, 1984-2020

Jean Thierry Ebogo-Belobo, Sebastien Kenmoe, Chris Andre Mbongue Mikangue · World Journal of Critical Care Medicine · 2023

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

40

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.